v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenues $ 24,642,564 $ 7,466,019
Cost of revenues 11,456,646 2,597,917
Gross profit 13,185,918 4,868,102
Operating expenses:    
Personnel 1,727,141 1,513,383
Marketing and promotion 224,369 112,384
General and administrative 3,170,724 2,235,009
Bad debts 1,025,415
Total operating expenses 6,147,649 3,860,776
Operating income 7,038,269 1,007,326
Non-operating income (expenses):    
Interest expense (1,512,022) (2,691,145)
Interest income 34,027 46,031
Loss on obligations settled with equity (1,286)
Change in fair value of investments (45,165) (687,002)
Total non-operating income (expenses), net (1,524,446) (3,332,116)
Income (loss) before income taxes 5,513,823 (2,324,790)
Provision for income taxes 1,203,797 12,926
Net income (loss) 4,310,026 (2,337,716)
Net income (loss) attributable to noncontrolling interests 90,123 83,728
Net income (loss) attributable to MariMed Inc. $ 4,219,903 $ (2,421,444)
Net income (loss) per share    
Basic $ 0.01 $ (0.01)
Diluted $ 0.01 $ (0.01)
Weighted average common shares outstanding    
Basic 305,212,269 230,829,366
Diluted 340,825,940 230,829,366

Source